Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the body's immune system mistakenly attacks healthy tissue, leading to inflammation and damage in various organs.
Systemic Lupus Erythematosus: AZD5492 Study
We are investigating a new medication for adults with systemic lupus erythematosus or idiopathic inflammatory myopathies. The study focuses on its safety and how the body processes the drug.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Idiopathic Inflammatory Myopathy
Idiopathic Inflammatory Myopathy (IIM) is a rare autoimmune condition characterized by muscle inflammation, leading to muscle weakness and pain without a known cause.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
Rheumatology
Bordeaux, France
Les Hopitaux Universitaires De Strasbourg
Rheumatology
Eckbolsheim, France
Centre Hospitalier Universitaire De Montpellier
Rheumatology
Montpellier, France
Sponsor: AstraZeneca AB
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.